ConductScience.org, home

Paper6540685

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.

Elliott JA and 8 others. Eur J Cancer Clin Oncol, 1984. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Papers, record 6540685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6540685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
PubMed
Journal
Eur J Cancer Clin Oncol
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
4.29
iCite
Revised in PubMed
2019-09-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elliott JAJ A
2Ahmedzai SS
3Hole DD
4Dorward AJA J
5Stevenson RDR D
6Kaye SBS B
7Banham SWS W
8Stack BHB H
9Calman KCK C

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
CarcinomaMajor topic
Lung NeoplasmsMajor topic
VinblastineMajor topic
Adenocarcinoma
Adult
Aged
Blood Cell Count
Carcinoma, Squamous Cell
Cisplatin
Female
Humans
Male
Middle Aged
Prognosis
Random Allocation
Vindesine

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
25929848Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.Cancer Discov2015https://conductscience.org/library/papers/25929848PubMed
12373594Platinum drugs in the treatment of non-small-cell lung cancer.Br J Cancer2002https://conductscience.org/library/papers/12373594PubMed
11027424Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.Br J Cancer2000https://conductscience.org/library/papers/11027424PubMed
8624270A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.Br J Cancer1996https://conductscience.org/library/papers/8624270PubMed
8262725Is there a role for vindesine in the treatment of non-small cell lung cancer?Invest New Drugs1993https://conductscience.org/library/papers/8262725PubMed
8130379Is the use of chemotherapy justified in non-small-cell lung cancer?Drugs Aging1994https://conductscience.org/library/papers/8130379PubMed
3801283Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro.Br J Cancer1986https://conductscience.org/library/papers/3801283PubMed
3022779Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media.Br J Cancer1986https://conductscience.org/library/papers/3022779PubMed
2157554A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2157554PubMed
2108816The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2108816PubMed
1325579Lung cancer: a review of current therapeutic modalities.Lung1992https://conductscience.org/library/papers/1325579PubMed
1283850Current options in the treatment of non-small cell lung cancer.Drugs1992https://conductscience.org/library/papers/1283850PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6540685

GET https://conductscience.org/api/papers/v1/6540685/authors